The directed differentiation of induced pluripotent stem cells (iPSCs) provides a scalable means to generate therapeutically relevant numbers of dendritic cells (DCs); however, as with many iPSC-derived cell types, iPSC-DCs do not reach full functional maturity and display limited immunogenicity. Researchers from the lab of Paul J.